State Street’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $179M | Sell |
|
|||||
|
2025
Q1 | $146M | Sell |
|
|||||
|
2024
Q4 | $190M | Buy |
|
|||||
|
2024
Q3 | $194M | Buy |
|
|||||
|
2024
Q2 | $200M | Buy |
|
|||||
|
2024
Q1 | $180M | Buy |
|
|||||
|
2023
Q4 | $203M | Buy |
|
|||||
|
2023
Q3 | $179M | Sell |
|
|||||
|
2023
Q2 | $163M | Sell |
|
|||||
|
2023
Q1 | $145M | Sell |
|
|||||
|
2022
Q4 | $159M | Buy |
|
|||||
|
2022
Q3 | $166M | Sell |
|
|||||
|
2022
Q2 | $156M | Buy |
|
|||||
|
2022
Q1 | $149M | Buy |
|
|||||
|
2021
Q4 | $119M | Buy |
|
|||||
|
2021
Q3 | $118M | Buy |
|
|||||
|
2021
Q2 | $129M | Sell |
|
|||||
|
2021
Q1 | $153M | Sell |
|
|||||
|
2020
Q4 | $221M | Buy |
|
|||||
|
2020
Q3 | $169M | Sell |
|
|||||
|
2020
Q2 | $212M | Sell |
|
|||||
|
2020
Q1 | $184M | Buy |
|
|||||
|
2019
Q4 | $232M | Buy |
|
|||||
|
2019
Q3 | $219M | Buy |
|
|||||
|
2019
Q2 | $230M | Buy |
|
|||||
|
2019
Q1 | $207M | Buy |
|
|||||
|
2018
Q4 | $137M | Sell |
|
|||||
|
2018
Q3 | $156M | Sell |
|
|||||
|
2018
Q2 | $127M | Buy |
|
|||||
|
2018
Q1 | $131M | Buy |
|
|||||
|
2017
Q4 | $138M | Sell |
|
|||||
|
2017
Q3 | $149M | Sell |
|
|||||
|
2017
Q2 | $151M | Sell |
|
|||||
|
2017
Q1 | $134M | Buy |
|
|||||
|
2016
Q4 | $133M | Sell |
|
|||||
|
2016
Q3 | $131M | Sell |
|
|||||
|
2016
Q2 | $98.9M | Buy |
|
|||||
|
2016
Q1 | $123M | Buy |
|
|||||
|
2015
Q4 | $163M | Buy |
|
|||||
|
2015
Q3 | $101M | Sell |
|
|||||
|
2015
Q2 | $144M | Sell |
|
|||||
|
2015
Q1 | $202M | Buy |
|
|||||
|
2014
Q4 | $159M | Sell |
|
|||||
|
2014
Q3 | $104M | Buy |
|
|||||
|
2014
Q2 | $82.9M | Sell |
|
|||||
|
2014
Q1 | $104M | Buy |
|
|||||
|
2013
Q4 | $95.4M | Sell |
|
|||||
|
2013
Q3 | $99.3M | Sell |
|
|||||
|
2013
Q2 | $72.8M | Buy |
|